- Home
- CGNT vs BCYC Comparison
CGNT vs BCYC Comparison
Compare CGNT & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGNT
- BCYC
- Stock Information
- Founded
- CGNT 2020
- BCYC 2009
- Country
- CGNT Israel
- BCYC United Kingdom
- Employees
- CGNT N/A
- BCYC N/A
- Industry
- CGNT Computer Software: Prepackaged Software
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- CGNT Technology
- BCYC Health Care
- Exchange
- CGNT Nasdaq
- BCYC Nasdaq
- Market Cap
- CGNT 617.3M
- BCYC 565.5M
- IPO Year
- CGNT N/A
- BCYC 2019
- Fundamental
- Price
- CGNT $8.42
- BCYC $6.53
- Analyst Decision
- CGNT Buy
- BCYC Buy
- Analyst Count
- CGNT 2
- BCYC 11
- Target Price
- CGNT $14.00
- BCYC $20.73
- AVG Volume (30 Days)
- CGNT 289.4K
- BCYC 324.0K
- Earning Date
- CGNT 12-10-2025
- BCYC 10-30-2025
- Dividend Yield
- CGNT N/A
- BCYC N/A
- EPS Growth
- CGNT N/A
- BCYC N/A
- EPS
- CGNT N/A
- BCYC N/A
- Revenue
- CGNT $376,566,000.00
- BCYC $28,339,000.00
- Revenue This Year
- CGNT $15.30
- BCYC N/A
- Revenue Next Year
- CGNT $11.30
- BCYC N/A
- P/E Ratio
- CGNT N/A
- BCYC N/A
- Revenue Growth
- CGNT 14.04
- BCYC N/A
- 52 Week Low
- CGNT $6.45
- BCYC $6.10
- 52 Week High
- CGNT $11.66
- BCYC $25.39
- Technical
- Relative Strength Index (RSI)
- CGNT 49.89
- BCYC 36.09
- Support Level
- CGNT $8.24
- BCYC $6.10
- Resistance Level
- CGNT $8.99
- BCYC $9.08
- Average True Range (ATR)
- CGNT 0.23
- BCYC 0.53
- MACD
- CGNT 0.04
- BCYC -0.24
- Stochastic Oscillator
- CGNT 43.96
- BCYC 12.42
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.